Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

8. BIOLOGICAL ASSETS: Schedule of assumptions used in valuation of Fair value of biological assets (Tables)

v3.21.2
8. BIOLOGICAL ASSETS: Schedule of assumptions used in valuation of Fair value of biological assets (Tables)
12 Months Ended
Dec. 31, 2020
Tables/Schedules  
Schedule of assumptions used in valuation of Fair value of biological assets

 

 

Weighted average assumption

10% Change of inputs ($)

Selling Price

$0.19

1,211,741

Yield by plant

71.41

1,147,615

Attrition

5.52%

70,859

Post-harvest costs ($/gram)

$0.01

262,754